Oncotarget cover image

Turning Immunosuppressive Tumors to Immunostimulatory: Nerofe and Doxorubicin's Impact

Oncotarget

00:00

Transforming Immunotherapy with Narofe and Doxorubicin: Research Breakthrough

Exploring the impact of Narofe and Doxorubicin on converting immunosuppressive tumors to immunostimulatory, targeting K-RAS G12C mutations for enhanced cancer treatment efficacy and immune response activation.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app